Prestige Consumer Healthcare (PBH) Tax Provisions (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Tax Provisions came in at $15.1 million in Q4 2025, down 20.94% year-on-year from $19.1 million in Q4 2024, and down 43.85% quarter-over-quarter from $26.9 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Tax Provisions (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Tax Provisions history runs 16 years deep, the most recent figure standing at $15.1 million for Q4 2025.
- On a quarterly basis, Tax Provisions fell 20.94% year-over-year to $15.1 million in Q4 2025; TTM through Dec 2025 was $80.2 million, a 26.04% increase from a year earlier, with the FY2025 full-year figure at $69.6 million, up 4.35% from the prior year.
- Tax Provisions slipped to $15.1 million in Q4 2025 per PBH's latest filing, from $26.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $26.9 million in Q3 2025 and bottomed at -$59.0 million in Q1 2023.
- The 5-year median for Tax Provisions is $15.6 million (2022), against an average of $12.1 million.
- Across the five-year window, Tax Provisions plunged 764.15% in 2023 and jumped 130.29% in 2024, its largest moves.
- Year by year, Tax Provisions stood at $15.3 million in 2021, then rose by 5.81% to $16.2 million in 2022, then gained by 2.25% to $16.5 million in 2023, then gained by 15.69% to $19.1 million in 2024, then dropped by 20.94% to $15.1 million in 2025.
- Per Business Quant, the three latest PBH Tax Provisions figures stand at $15.1 million (Q4 2025), $26.9 million (Q3 2025), and $14.3 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.12 Mn |
| Sep 30, 2025 | 26.92 Mn |
| Jun 30, 2025 | 14.31 Mn |
| Mar 31, 2025 | 23.83 Mn |
| Dec 31, 2024 | 19.12 Mn |
| Sep 30, 2024 | 17.29 Mn |
| Jun 30, 2024 | 9.35 Mn |
| Mar 31, 2024 | 17.86 Mn |
| Dec 31, 2023 | 16.53 Mn |
| Sep 30, 2023 | 16.86 Mn |
| Jun 30, 2023 | 15.44 Mn |
| Mar 31, 2023 | -58.97 Mn |
| Dec 31, 2022 | 16.17 Mn |
| Sep 30, 2022 | 15.57 Mn |
| Jun 30, 2022 | 15.63 Mn |
| Mar 31, 2022 | 8.88 Mn |
| Dec 31, 2021 | 15.28 Mn |
| Sep 30, 2021 | 14.31 Mn |
| Jun 30, 2021 | 18.62 Mn |
| Mar 31, 2021 | 4.86 Mn |